semaglutide type 1 diabetes randomized trial 2024 in Early New Science Suggests Semaglutide Improves

J.Sakurai-SaitoY.et al

Five-day dosing compresses this recovery window

These medications may help eligible patients feel fuller sooner, reduce appetite, slow stomach emptying, and support improved eating behaviors when combined with nutrition, movement, and lifestyle changes

Mller M, Hermes GDA, Emanuel E C, Holst JJ, Zoetendal EG, Smidt H, Troost F, Schaap FG, Damink SO, Jocken JWE, Lenaerts K, Masclee AAM, Blaak EE

Once-weekly semaglutide, compared to automated insulin delivery (AID) alone, improved the composite outcome of time in range (TIR) 70% and promoted a 5% reduction in body weight among adults living with type 1 diabetes and obesity currently on AID therapy